Showing results (191-200 of 255) with videos related to
Sort By:
Pageof 26
Lancet (London, England)|November 19, 2010
Clostridium difficile infection in Europe: a hospital-based surveyMartijn P Bauer, Daan W Notermans, Birgit H B van Benthem, et al.Plos One|December 31, 2013
Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic reviewEroboghene H Otete, Anand S Ahankari, Helen Jones, et al.Anaerobe|July 23, 2021
Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samplesArik Elfassy, Warren V Kalina, Roger French, et al.Journal of Medical Microbiology|March 21, 2020
A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infectionsStephanie Noviello, G Ralph Corey, Thomas L Holland, et al.Antimicrobial Agents and Chemotherapy|June 10, 2020
In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficileKhurshida Begum, Eugénie Bassères, Julie Miranda, et al.The Journal of Antimicrobial Chemotherapy|July 29, 2020
In vitro activity of eravacycline against common ribotypes of Clostridioides difficileEugénie Bassères, Khurshida Begum, Chris Lancaster, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 4, 2012
Predictors of first recurrence of Clostridium difficile infection: implications for initial managementDavid W Eyre, A Sarah Walker, David Wyllie, et al.The Journal of Antimicrobial Chemotherapy|January 11, 2022
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolonesMaria J G T Vehreschild, Annie Ducher, Thomas Louie, et al.Frontiers in Cellular and Infection Microbiology|July 19, 2021
Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot StudyAnthony M Buckley, Ines B Moura, Norie Arai, et al.Msphere|May 8, 2020
Genetic Association Reveals Protection against Recurrence of Clostridium difficile Infection with Bezlotoxumab TreatmentJudong Shen, Devan V Mehrotra, Mary Beth Dorr, et al.Pageof 26